CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2023 GI Fellow Board of Advisors
Embassy of Education
Live Events Slide Library Webcasts & Podcasts Abstract Library Committee Members
 
HCV-Single Disease Content  
Featured Article

Live CME Meetings

Triple E for HCV: Treatment Expansion in High-Risk Communities: Engagement, Education and Eradication of HCV

This activity was developed for primary care physicians and health care professionals in the primary care field who manage patients with HCV and wish to improve standard practice care.
Recorded Educational Webinar

Webcasts
     
HCV Elimination Starts With You: A Call to Action for all Healthcare Providers   Educational Webcast
HBV, HCV, and HDV   Educational Webcast
Hepatitis C: Screening, Barriers and Access to Therapy   CME Audiocast
Management Challenges in HCV   CME Audiocast
The Role of Non-Invasive Biomarkers in Managing Patients with HCV   Educational Webinar
Podcasts
     
HCV 101 - Confidently Treat HCV in any Setting   Educational Podcast
CME eNewsletter
     
  Newsletter  
     
  Credit Designation  
  1.0 AMA PRA  
  Category 1 Credit(s)™  
  Download  
     
  ACHS  
  Jointly sponsored by The Annenberg Center for Health Sciences at Eisenhower and the
Chronic Liver Disease Foundation.

This educational material was supported by an educational grant from AbbVie and Gilead. 		 
     
 
 
Triple E for HCV: Engagement, Education, and Eradication of HCV Among Patients with Substance Use Disorders
 
Target Audience
This activity is targeted to physicians and other health care providers who specialize in the management of patients with addictive disorders.
 
Educational Objectives
Upon completion of this activity, participants should be better able to:
• Recognize the risks of exposure to HCV in injection drug users and identify epidemiologic trends of HCV infection in this population
• Describe the natural history of chronic HCV infection
• Demonstrate how proper HCV screening and diagnosis, as well as implementation of antiviral therapy, can improve long term outcomes in injection drug users
 
Accreditation Statement
Please see page 1 of the newsletter for full accreditation statement.
 
 
 
Dynamic CME Resource Library
     
The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging Populations   CME eNewsletter
Management of Hep C/HIV Infection   Educational eNewsletter
Slide Library
   Released: 2023
Webcast
HCV Elimination Starts With You: A Call to Action for All Healthcare Providers
43 slides
 
 
   Released: 2021
Webcast
Triple E for HCV: Engagement, Education and Eradication - ASAM
68 slides
 
 
   Released: 2020
Webcast
Triple E for HCV: Engagement, Education, and Eradication
70 slides
 
 
   Released: 2020
test
Hepatitis C: Screening, Barriers and Access to Therapy
28 slides
 
 
   Released: 2019
Webcast
AATOD Conference
159 slides
 
 
   Released: 2019
Webcast
Triple E for HCV Satellite Symposium - NCCHC
81 slides
 
 
   Released: 2019
Webcast
Hot Topics in Cirrhosis
120 slides
 
 
   Released: 2019
Webcast
Triple E for HCV Satellite Symposium - ASAM
75 slides
 
 
   Released: 2019
Webcast
Hepatology News Tonight Managing Complications of Cirrhosis
129 slides
 
 
   Released: 2018
test
HCV Advances 2018
51 slides
 
 
   Released: 2018
test
Hepatology News Tonight: Managing Complication of Cirrhosis
57 slides
 
 
   Released: 2018
Webcast
Hepatitis Elimination Symposium and Workshop
96 slides
 
 
   Released: 2017
Webcast
HCV Advances 2017
54 slides
 
 
   Released: 2017
Webcast
Expert Perspectives: Highlights on HCV from EASL 2017
61 slides
 
 
   Released: 2016
Webcast
Expert Perspectives: Best of HCV - 2016 Spring Update
82 slides
 
 
     
 
 
Abstract Library
1.Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
 

Adv Ther. 2023 Aug;40(8):3465-3477. doi: 10.1007/s12325-023-02539-5. Epub 2023 Jun 7.

 

Anthony Martinez 1, Wei-Han Cheng 2, Steven E Marx 2, Shivaji Manthena 2, Douglas E Dylla 2, Lauren Wilson 3, Emmanuel Thomas 4
 
2.Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort study
 

Lancet Reg Health Am. 2023 May 17;22:100490. doi: 10.1016/j.lana.2023.100490.eCollection 2023 Jun.

 

Bernadette Lettner 1, Kate Mason 1, Zoë R Greenwald 2 3, Jennifer Broad 1, Erin Mandel 4, Jordan J Feld 4, Jeff Powis 5
 
3.Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors
 

Am J Gastroenterol. 2023 Jul 10. doi: 10.14309/ajg.0000000000002361. Online ahead of print.

 

Marcel Yibirin 1, Khalis Mustafayev 1, Jeff Hosry 1, Pooja Pundhir 1, Joseph Klingen 1, Eduardo Yepez Guevara 1, Bruno P Granwehr 1, Ahmed Kaseb 2, Aung Naing 3, Sapna Patel 4, Amishi Y Shah 5, Ferdinandos Skoulidis 6, Hussein A Tawbi 4, Lan Wang 7, Ethan Miller 7, Hao Chi Zhang 7, Amado Zurita-Saavedra 5, Harrys A Torres 1 7
 
4.Hepatitis C: recent advances and practical management
 

Frontline Gastroenterol. 2023 Jun 13;14(5):415-421.doi: 10.1136/flgastro-2022-102373. eCollection 2023.

 

Rebecca O' Kane 1, Emma Hathorn 1
 
5.Retrospective analysis of vertical Hepatitis C exposure and infection in children in Western New York
 

BMC Gastroenterol. 2023 Jul 17;23(1):242. doi: 10.1186/s12876-023-02871-8.

 

Ndeye Licka Dieye 1 2, Mine Varol 1, Shauna C Zorich 2, Amy E Millen 2, Karl O A Yu 1, Oscar G Gómez-Duarte 3 4
 
6.Hepatitis C virus RNA is 5
 

Nature. 2023 Jul;619(7971):811-818. doi: 10.1038/s41586-023-06301-3. Epub 2023 Jul 5.

 

Anna V Sherwood # 1, Lizandro R Rivera-Rangel # 2 3, Line A Ryberg 2 3, Helena S Larsen 2 3, Klara M Anker 1, Rui Costa 2 3, Cathrine B Vågbø 4, Eva Jakljevic 2 3, Long V Pham 2 3, Carlota Fernandez-Antunez 2 3, Gabriele Indrisiunaite 1, Agnieszka Podolska-Charlery 1, Julius E R Grothen 1, Nicklas W Langvad 1, Nicolas Fossat 2 3, Anna Offersgaard 2 3, Amal Al-Chaer 1, Louise Nielsen 2 3, Anna Kusnierczyk 4, Christina Sølund 5 6, Nina Weis 5 6, Judith M Gottwein 2 3, Kenn Holmbeck 2 3, Sandro Bottaro 7, Santseharay Ramirez 2 3, Jens Bukh 8 9, Troels K H Scheel 10 11 12, Jeppe Vinther 13

Nature. 2023 Jul;619(7971):811-818. doi: 10.1038/s41586-023-06301-3. Epub 2023 Jul 5.

 

Anna V Sherwood # 1, Lizandro R Rivera-Rangel # 2 3, Line A Ryberg 2 3, Helena S Larsen 2 3, Klara M Anker 1, Rui Costa 2 3, Cathrine B Vågbø 4, Eva Jakljevic 2 3, Long V Pham 2 3, Carlota Fernandez-Antunez 2 3, Gabriele Indrisiunaite 1, Agnieszka Podolska-Charlery 
 
7.Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy-Boston, Massachusetts, 2016-2021
 

Open Forum Infect Dis. 2023 Jul 5;10(7):ofad342. doi: 10.1093/ofid/ofad342.eCollection 2023 Jul.

 

Akash Gupta 1 2, Dina Ashour 1, Fatma M Shebl 1, Laura Platt 1 3, John J Chiosi 1 2, Sandra B Nelson 2, Kevin L Ard 2, Arthur Y Kim 2, Ingrid V Bassett 1 2
 
8.Treatment Outcomes of Sofosbuvir/Velpatasvir/Voxilaprevir in Direct-Acting Antiviral-Experienced Hepatitis C Virus Patients: A Systematic Review and Meta-Analysis
 

Viruses. 2023 Jun 30;15(7):1489. doi: 10.3390/v15071489.

 

Pooja Devan 1, Kai Le Ashley Tiong 1, Jean Ee Neo 1, Babu P Mohan 2, Karn Wijarnpreecha 3, Yew Chong Steve Tam 4, Nicola Coppola 5, Carmen Monica Preda 6, Yu Jun Wong 1 7 8
 
9.'I'm not hep C free': afterlives of hepatitis C in the era of cure
 

Med Humanit. 2023 Jul 14;medhum-2023-012653. doi: 10.1136/medhum-2023-012653.Online ahead of print.

 

Dion Kagan 1, Kate Seear 2, Emily Lenton 2, Adrian Farrugia 2, Kylie Valentine 3, Sean Mulcahy 2
 
10.Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot
 

BMC Infect Dis. 2023 Jun 7;23(1):384. doi: 10.1186/s12879-023-08362-1.

 

Dominik Stämpfli 1 2 3, Tamara Leila Imfeld-Isenegger 4 5, Kurt E Hersberger 6 5, Markus Messerli 6 5
 
11.Temporal trends in hepatitis C-related hospitalizations, United States, 2000-2019
 

Clin Infect Dis. 2023 Jul 18;ciad425. doi: 10.1093/cid/ciad425. Online ahead of print.

 

Megan G Hofmeister 1, Yuna Zhong 1, Anne C Moorman 1, Christina R Samuel 1, Eyasu H Teshale 1, Philip R Spradling 1
 
12.Beyond donation to organ utilization in the USA
 

Curr Opin Organ Transplant. 2023 Jun 1;28(3):197-206.doi: 10.1097/MOT.0000000000001060. Epub 2023 Mar 9.

 

Darren Stewart 1, Richard Hasz 2, Bonnie Lonze 1
 
13.Acceptability and usability of oral fluid HCV self-testing for hepatitis C diagnosis: A systematic review and meta-analysis
 

J Viral Hepat. 2023 Jul 23. doi: 10.1111/jvh.13876. Online ahead of print.

 

Hugo Perazzo 1, Rodolfo Castro 2 3, Cristiane Villela-Nogueira 4, Marcos Torres 1, Samara Luiza Silva 1, Sandra W Cardoso 1, Beatriz Grinsztejn 1, Valdilea G Veloso 1
 
14.Increasing Treatment Rates for Hepatitis C in Primary Care
 

J Am Board Fam Med. 2023 Aug 9;36(4):591-602. doi: 10.3122/jabfm.2022.220427R1.Epub 2023 Jul 19.

 

Ann Stewart 1, Amy Craig-Neil 1, Kathryn Hodwitz 1, Rick Wang 1, Doret Cheng 1, Gordon Arbess 1, Caroline Jeon 1, Clara Juando-Prats 1, Tara Kiran 1
 
15.Successes in antiviral drug discovery: a tribute to Nick Meanwell
 

Med Chem Res. 2023 Jun 8;1-10. doi: 10.1007/s00044-023-03086-y.Online ahead of print.

 

David P Rotella 1
 
16.Red Palms' Syndrome and Red Fingers' Syndrome: A Mini Review
 

Angiology. 2023 Jul 6;33197231185459. doi: 10.1177/00033197231185459.Online ahead of print.

 

Salvino Bilancini 1, Massimo Lucchi 1, Sandro Tucci 1, Federica Pomella 2, Giulia Vittori 1, Pierluigi Edgard Mollo 3, Giusto Trevisan 4
 
17.Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients
 

J Clin Psychiatry. 2023 Jul 31;84(5):22m14623. doi: 10.4088/JCP.22m14623.

 

Erin Mandel 1 2, Mia J Biondi 3 4, Andrew Mendlowitz 1 3, Margaret Maheandiran 5, Elizabeth Hollingdrake 5, Aaron Vanderhoff 3, Brett Wolfson-Stofko 3, Camelia Capraru 3, Jordan J Feld 1 3, Renee Logan 5
 
18.Beyond donation to organ utilization in the USA
 

Curr Opin Organ Transplant. 2023 Jun 1;28(3):197-206.doi: 10.1097/MOT.0000000000001060. Epub 2023 Mar 9.

 

Darren Stewart 1, Richard Hasz 2, Bonnie Lonze 1
 
19.Acceptability and usability of oral fluid HCV self-testing for hepatitis C diagnosis: A systematic review and meta-analysis
 

J Viral Hepat. 2023 Jul 23. doi: 10.1111/jvh.13876. Online ahead of print.

 

Hugo Perazzo 1, Rodolfo Castro 2 3, Cristiane Villela-Nogueira 4, Marcos Torres 1, Samara Luiza Silva 1, Sandra W Cardoso 1, Beatriz Grinsztejn 1, Valdilea G Veloso 1
 
20.Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection
 

 Addict Dis. 2023 Jul-Sep;41(3):213-224.doi: 10.1080/10550887.2022.2088978. Epub 2022 Aug 3.

 

Olav Dalgard 1, Alain H Litwin 2, Oren Shibolet 3, Jason Grebely 4, Ronald Nahass 5, Frederick L Altice 6, Brian Conway 7, Edward J Gane 8, Anne F Luetkemeyer 9, Cheng-Yuan Peng 10, David Iser 11, Isaias Noel Gendrano 12, Michelle M Kelly 12, Barbara A Haber 12, Heather Platt 12, Amy Puenpatom 12; CO-STAR Investigators
 
21.Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response
 

JTCVS Open. 2023 Mar 10;14:602-614. doi: 10.1016/j.xjon.2023.02.014.eCollection 2023 Jun.

 

Mauricio A Villavicencio 1, Selena S Li 2, Ann Marie Leifer 2, Jenna L Gustafson 3, Asishana Osho 2, Stanley Wolfe 2, Yuval Raz 4, Jason Griffith 4, Isabel Neuringer 4, Emily Bethea 3, Thais Gift 5, Georgina Waldman 5, Todd Astor 4, Nathaniel B Langer 2, Raymond T Chung 3
 
22.Hepatitis C Virus-HIV Coinfection in the United States Among People Who Inject Drugs: Data Needed for Ending Dual Epidemics
 

Public Health Rep. 2023 Jul 22;333549231181348.doi: 10.1177/00333549231181348. Online ahead of print.

 

Anne C Moorman 1, Danae Bixler 1, Eyasu H Teshale 1, Megan Hofmeister 1, Henry Roberts 1, Johanna Chapin-Bardales 2, Neil Gupta 1
 
23.Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis
 

Clin Gastroenterol Hepatol. 2023 Jul;21(7):1723-1738.e5.doi: 10.1016/j.cgh.2022.04.013. Epub 2022 May 5.

 

Nicole J Kim 1, Philip Vutien 2, Erin Cleveland 2, Anne Cravero 3, George N Ioannou 4
 
24.Hepatitis C Elimination: Opportunities and Challenges in 2023
 

Viruses. 2023 Jun 22;15(7):1413. doi: 10.3390/v15071413.

 

Gadeer Taha 1, Levy Ezra 2, Naim Abu-Freha 3 4
 
25.Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis
 

Lancet Gastroenterol Hepatol. 2023 Jun;8(6):533-552.doi: 10.1016/S2468-1253(23)00018-3. Epub 2023 Mar 27.

 

Adelina Artenie 1, Jack Stone 2, Hannah Fraser 2, Daniel Stewart 3, Chiedozie Arum 4, Aaron G Lim 2, Anna L McNaughton 2, Adam Trickey 2, Zoe Ward 2, Daniela Abramovitz 5, Michel Alary 6, Jacquie Astemborski 7, Julie Bruneau 8, Steven J Clipman 9, Carla S Coffin 10, Sara Croxford 11, Kora DeBeck 12, Eva Emanuel 13, Kanna Hayashi 14, Joumana G Hermez 15, Daniel Low-Beer 16, Niklas Luhmann 16, Gisela Macphail 17, Lisa Maher 18, Norah E Palmateer 19, Eshan U Patel 20, Rachel Sacks-Davis 21, Wijnand Van Den Boom 22, Daniela K van Santen 23, Josephine G Walker 24, Matthew Hickman 2, Peter Vickerman 2; HIV and HCV Incidence Review Collaborative Group

 

 

Collaborators

  • HIV and HCV Incidence Review Collaborative Group: 

Malvina Aladashvili, Tasnim Azim, Paul Dietze, Kostyantyn Dumchev, Jennifer R Havens, Margaret Hellard, Sharon Hutchinson, Jennifer Iversen, Ali Judd, Martin Kåberg, Ann E Kurth, Shruti H Mehta, Viktor Mravcík, Maria Prins, Sunil S Solomon, Steffanie A Strathdee, Vana Sypsa, Catherine S Todd, Jorge Valencia, Ernst Wisse
 
View More
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.